Cargando…
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Inter...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349028/ https://www.ncbi.nlm.nih.gov/pubmed/34362409 http://dx.doi.org/10.1186/s13063-021-05500-5 |
_version_ | 1783735484460040192 |
---|---|
author | Yeung, Kar-Fu Gandhi, Mihir Lam, Amanda Yun Rui Julianty, Selly Chia, Alvin Yeow Meng Tan, Gilbert Choon Seng Goh, Su-Yen Ho, Emily Tse Lin Koh, Angela Fang Yung Tan, Gavin Siew Wei Shum, Eugene Jin Wen Finkelstein, Eric A. Jafar, Tazeen H. Teoh, Yee Leong van Dam, Rob M. Whitton, Clare Thumboo, Julian Bee, Yong Mong |
author_facet | Yeung, Kar-Fu Gandhi, Mihir Lam, Amanda Yun Rui Julianty, Selly Chia, Alvin Yeow Meng Tan, Gilbert Choon Seng Goh, Su-Yen Ho, Emily Tse Lin Koh, Angela Fang Yung Tan, Gavin Siew Wei Shum, Eugene Jin Wen Finkelstein, Eric A. Jafar, Tazeen H. Teoh, Yee Leong van Dam, Rob M. Whitton, Clare Thumboo, Julian Bee, Yong Mong |
author_sort | Yeung, Kar-Fu |
collection | PubMed |
description | BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. METHODS: This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. DISCUSSION: The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. TRIAL REGISTRATION: ClinicalTrials.govNCT03503942. Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05500-5. |
format | Online Article Text |
id | pubmed-8349028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83490282021-08-09 The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial Yeung, Kar-Fu Gandhi, Mihir Lam, Amanda Yun Rui Julianty, Selly Chia, Alvin Yeow Meng Tan, Gilbert Choon Seng Goh, Su-Yen Ho, Emily Tse Lin Koh, Angela Fang Yung Tan, Gavin Siew Wei Shum, Eugene Jin Wen Finkelstein, Eric A. Jafar, Tazeen H. Teoh, Yee Leong van Dam, Rob M. Whitton, Clare Thumboo, Julian Bee, Yong Mong Trials Study Protocol BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. METHODS: This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. DISCUSSION: The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. TRIAL REGISTRATION: ClinicalTrials.govNCT03503942. Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05500-5. BioMed Central 2021-08-06 /pmc/articles/PMC8349028/ /pubmed/34362409 http://dx.doi.org/10.1186/s13063-021-05500-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Yeung, Kar-Fu Gandhi, Mihir Lam, Amanda Yun Rui Julianty, Selly Chia, Alvin Yeow Meng Tan, Gilbert Choon Seng Goh, Su-Yen Ho, Emily Tse Lin Koh, Angela Fang Yung Tan, Gavin Siew Wei Shum, Eugene Jin Wen Finkelstein, Eric A. Jafar, Tazeen H. Teoh, Yee Leong van Dam, Rob M. Whitton, Clare Thumboo, Julian Bee, Yong Mong The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial |
title | The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial |
title_full | The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial |
title_fullStr | The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial |
title_full_unstemmed | The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial |
title_short | The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial |
title_sort | pre-diabetes interventions and continued tracking to ease-out diabetes (pre-dicted) program: study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349028/ https://www.ncbi.nlm.nih.gov/pubmed/34362409 http://dx.doi.org/10.1186/s13063-021-05500-5 |
work_keys_str_mv | AT yeungkarfu theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT gandhimihir theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT lamamandayunrui theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT juliantyselly theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT chiaalvinyeowmeng theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT tangilbertchoonseng theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT gohsuyen theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT hoemilytselin theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT kohangelafangyung theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT tangavinsiewwei theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT shumeugenejinwen theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT finkelsteinerica theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT jafartazeenh theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT teohyeeleong theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT vandamrobm theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT whittonclare theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT thumboojulian theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT beeyongmong theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT yeungkarfu prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT gandhimihir prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT lamamandayunrui prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT juliantyselly prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT chiaalvinyeowmeng prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT tangilbertchoonseng prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT gohsuyen prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT hoemilytselin prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT kohangelafangyung prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT tangavinsiewwei prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT shumeugenejinwen prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT finkelsteinerica prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT jafartazeenh prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT teohyeeleong prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT vandamrobm prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT whittonclare prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT thumboojulian prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial AT beeyongmong prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial |